Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 80-86

  Guarnieri, Gabriella ^a   Zanatta, Elisabetta ^a   Mason, Paola ^a   Scarpa, Maria Cristina ^a   Pigatto, Erika ^a   Maestrelli, Piero ^a   Cozzi, Franco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Capillary volume; Carbon monoxide; Interstitial lung diseases; Membrane conductance; Nitric oxide

Indexed keywords

CARBON DIOXIDE; NITRIC OXIDE; BIOLOGICAL MARKER; CARBON MONOXIDE;

ADULT; ALVEOLAR CAPILLARY MEMBRANE CONDUCTANCE; ARTICLE; BLOOD GAS DIFFUSION BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG GAS EXCHANGE; MALE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PULMONARY CAPILLARY BLOOD VOLUME; PULMONARY HYPERTENSION; RESPIRATORY TRACT PARAMETERS; SCORING SYSTEM; SYSTEMIC SCLEROSIS; BLOOD; BLOOD EYE BARRIER; BREATH ANALYSIS; CAPILLARY PERMEABILITY; CASE CONTROL STUDY; COMPLICATION; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES, INTERSTITIAL; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SCLERODERMA, SYSTEMIC; SPIROMETRY;

ADULT; BIOLOGICAL MARKERS; BLOOD-AQUEOUS BARRIER; BREATH TESTS; CAPILLARY PERMEABILITY; CARBON MONOXIDE; CASE-CONTROL STUDIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; SCLERODERMA, SYSTEMIC; SPIROMETRY;

EID: 84946224723     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. NIHTYANOVA SI, ONG VH, DENTON CP: Current management strategies for systemic sclerosis. Clin Exp Rheumatol 2014; 32 (Suppl. 81): S156-S164.
2. TYNDALL AJ, BANNERT B, VONK M et al.: Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
3. FERRI C, VALENTINI G, COZZI F et al.: Demographic, clinical, and serologic features and survival in 1,021 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
4. BOUROS D, WELLS AU, NICHOLSON AG et al.: Histopathologic subset of fibrosingalveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-6.
5. MUKERJEE D, ST GEORGE D, COLEIRO B et al.: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
6. IUDICI M, CODULLO V, GIUGGIOLI D et al.: Pulmonary hypertension in systemic slerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Clin Exp Rheumatol 2013; 31 (Suppl. 76): 31-6.
7. KHANNA D, MERKEL PA: Outcome measures in systemic sclerosis: an update on instruments and current research. Curr Rheumatol Rep 2007; 9: 151-7.
8. ROUGHTON FLW, FOSTER RE: Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special references to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 1957; 11: 290-302.
9. OVERBEEK MJ, GROEPENHOFF H, VOSKUYL AE et al.: Membrane diffusion and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study. Respir Res 2008; 9: 68.
10. PERNOT J, PUZENAT E, MAGY-BERTRAND N et al.: Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide. Respiration 2012; 84: 461-8.
11. SIVOVA N, LAUNAY D, WéMEAU-STERVIN-OU L et al.: Relevance of portioning DLCO to detect pulmonary hypertension in Systemic Sclerosis. Plos One 2013; 8: e78001.
12. MASI AT: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diag-nostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
13. STROLLO D, GOLDIN J: Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep 2010; 12: 156-61.
14. GALIE N, HOEPER MM, HUMBERT M et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-63.
15. MILLER MR, HANKINSON J, BRUSASCO V et al.: Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. MACINTYRE N, CRAPO RO, VIEGI G et al.: Standardisation of single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-35.
17. Commission Des Communutes Eeuropeennes (CEeCA): Table de reference pour les exames spirometriques. Luxembourg; office des publications officiels des Communutés Européennes, 1971.
18. COTES JE, CHINN DJ, QUANJER PH, ROCA J, YERNAULT JC: Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993; 6 (Suppl. 16): 41-52.
19. ZAVORSKY GS, CAO J, MURIAS JM: Reference values of pulmonary diffusing capacity for nitric oxide in an adult population. Nitric Oxide 2008; 18: 70-9.
20. FOSTER RE: Diffusion of gases across the alveolar capillary membrane, In: FAHRI LE, TENNEY SM (Eds.), Handbook of Physiology, The Respiratory System, Gas Exchange. American Physiological Society, Washington, DC, 1987, pp.71-88.
21. WéMEAU-STERVINOU L, PEREZ T, MURPHY C et al.: Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Respir Med 2012; 106: 564-70.
22. VaAn dDer LEE I, ZANEN P, STIGER N, vaVAn dDen BOSCH LM, LAMMERS JW: Diffusing capacity for nitric oxide and carbon monoxide in patients with diffused parenchymal lung disease and pulmonary arterial hypertension. Chest 2006; 129: 378-83.
23. PHANSALKAR A, HANSON CM, SHAKIR AR et al.: Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis. Am J Respir Crit Care Med 2004; 169: 1034-40.
24. LAMBERTO C, NUNES H, Le TOUMELIN P et al.: Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 2004; 125: 2061-8.
25. BONAY M, BANCAL C, dDe ZUTTERE D et al.: Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure. Chest 2004; 126: 1460-6.
26. MORGAN JM, GRIFFITHS M, dDu BOIS RM, EVANS TW: Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest 1991; 99: 551-6.
27. FARHA S, LASKOWSKI D, GEORGE D et al.: Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respir Res 2013; 14: 6.
28. OPPENHEIMER BW, BERGER KI, HADJIAN-GELIS NP, NORMAN NG, RAPOPORT DM, GOLDRING RM: Membrane diffusion in diseases of the pulmonary vasculature. Respir Med 2006; 100: 1247-53.
29. BORLAND CD, DUNNINGHAM H, BOTTRIL F et al.: Significant blood resistance to nitric oxide transfer in the lung. J Appl Physiol 2010; 108: 1052-60.
30. BARNES J, MAYES MD: Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012; 24: 165-70.